Search

Author/Creator Beswick, L.

1. Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients. Issue 6 (June 2015)

Authors:
Costello, S. P.; Ghaly, S.; Beswick, L.; Pudipeddi, A.; Agarwal, A.; Sechi, A.; O'Connor, S.; Connor, S. J.; Sparrow, M. P.; Bampton, P.; Walsh, A. J.; Andrews, J. M.; Australian Inflammatory Bowel Disease Association (AIBDA)
Journal:
Internal medicine journal
Issue:
Volume 45:Issue 6(2015)
Page Start:
659
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications. Issue 12 (December 2014)

Authors:
Beswick, L.; Ting, A.; Macrae, F.; Dowling, D.; Hair, C.
Journal:
Internal medicine journal
Issue:
Volume 44:Issue 12a(2014)
Page Start:
1264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dose tailoring of anti‐tumour necrosis factor‐alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response. Issue 2 (February 2015)

Authors:
Ghaly, S.; Costello, S.; Beswick, L.; Pudipeddi, A.; Agarwal, A.; Sechi, A.; Antoniades, S.; Headon, B.; Connor, S.; Lawrance, I. C.; Sparrow, M.; Walsh, A. J.; Andrews, J. M.; AIBDA
Journal:
Internal medicine journal
Issue:
Volume 45:Issue 2(2015)
Page Start:
170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗